Entinostat: Phase I/II data

Top-line data from 37 evaluable patients with metastatic clear cell RCC who have completed one 84-day cycle in

Read the full 186 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE